Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antiphospholipid antibodies and COVID-19 thrombotic vasculopathy: one swallow does not make a summer
Pier Luigi Meroni, María Orietta Borghi
Annals of the Rheumatic Diseases (2021) Vol. 80, Iss. 9, pp. 1105-1107
Open Access | Times Cited: 16

Showing 16 citing articles:

Autoantibodies in COVID-19: implications for disease severity and clinical outcomes
Yannick Galipeau, Curtis Cooper, Marc‐André Langlois
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies
Jan Damoiseaux, Arad Dotan, Marvin J. Fritzler, et al.
Autoimmunity Reviews (2021) Vol. 21, Iss. 3, pp. 103012-103012
Open Access | Times Cited: 75
Modern concept of autoimmunity in rheumatology
Е. Л. Насонов
Rheumatology Science and Practice (2023) Vol. 61, Iss. 4, pp. 397-420
Open Access | Times Cited: 16
Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects
Е. Л. Насонов
Rheumatology Science and Practice (2024) Vol. 62, Iss. 1, pp. 32-54
Open Access | Times Cited: 5
Immunohematologic Biomarkers in COVID-19: Insights into Pathogenesis, Prognosis, and Prevention
David R. Sweet, Michael L. Freeman, David A. Zidar
Pathogens and Immunity (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 10
Deficiency in the production of antibodies to lipids correlates with increased lipid metabolism in severe COVID-19 patients
Ignacio Piédrola, Sara Martínez, Ana Gradillas, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients.
Pier Luigi Meroni, Stefania Croci, Paola Adele Lonati, et al.
Autoimmunity Reviews (2022) Vol. 22, Iss. 1, pp. 103232-103232
Open Access | Times Cited: 9
Role of β2‐glycoprotein I in the pathogenesis of the antiphospholipid syndrome
Jing Li, Xiangrui Zhu, Juan Feng
Rheumatology & autoimmunity (2023) Vol. 3, Iss. 3, pp. 131-139
Open Access | Times Cited: 4
Thrombosis and Hyperinflammation in COVID-19 Acute Phase Are Related to Anti-Phosphatidylserine and Anti-Phosphatidylinositol Antibody Positivity
Jaume Alijotas‐Reig, Ariadna Anunciación-Llunell, Stephanie Morales-Pérez, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2301-2301
Open Access | Times Cited: 4
TO SHOw how we have been ENgaged in the APS FiELD (What we learned on APS collaborating with Professor Yehuda Shoenfeld)
Pier Luigi Meroni, María Orietta Borghi, Elena Raschi, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 9, pp. 103613-103613
Closed Access
Prevalence and Clinical Significance of Antiphospholipid Antibodies in Hospitalized Patients With COVID-19 Infection
Navkirat Kahlon, Pejma Shazadeh Safavi, Ziad Abuhelwa, et al.
Cureus (2022)
Open Access | Times Cited: 2
Evaluating the Relationship Between Antiphospholipid Antibodies and COVID-19 Severity
Alireza Sadeghi, Masumeh Hasanlu, A A Hosseinpour Feyzi, et al.
DNA and Cell Biology (2022) Vol. 42, Iss. 1, pp. 65-71
Closed Access | Times Cited: 1
Humoral immunity and thrombosis in COVID-19
G. Lasagni, María Orietta Borghi, Massimo Cugno, et al.
Elsevier eBooks (2023), pp. 375-392
Closed Access
Setting a context for autoantibodies, autoimmunity, and autoimmune diseases associated with SARS-CoV2
Marvin J. Fritzler
Elsevier eBooks (2023), pp. 1-16
Closed Access
COVID-19 in patients with Systemic Lupus Erythematosus and the antiphospholipid syndrome
Francesca Crisafulli, Silvia-Ebe-Lucia Della-Pina, Giulia Fontana, et al.
Elsevier eBooks (2023), pp. 529-555
Closed Access
Response to: Correspondence on ‘Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients’ by Liu
Marvin J. Fritzler, Uriel Trahtemberg
Annals of the Rheumatic Diseases (2021) Vol. 82, Iss. 8, pp. e180-e180
Closed Access
Page 1

Scroll to top